Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 20, 2022--
The "Antibacterial Drugs Market, by Drug Class, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
Antibacterial drugs are derived from bacteria or molds. These antibacterial drugs are synthesized from simple molecules to form complex molecules. Antibiotics work in a variety of ways, such as inhibiting cell wall production, increasing cell membrane permeability, and interfering with protein synthesis, nucleic acid metabolism, and other metabolic processes by inhibiting cell wall production, nucleic acid metabolism, and other metabolic processes. Antibiotics can raise or lower the serum levels of other medications by increasing or decreasing their metabolism. The most clinically important interactions involve drugs with a low therapeutic ratio. Other drugs can also increase or decrease levels of antibiotics. Antibacterial drugs include a range of powerful drugs such as phenoxymethylpenicillin, penicillin V. and are used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs.
Market Dynamics
Increasing inorganic activities such as partnerships among market players is expected to drive the global antibacterial drugs market growth over the forecast period. For instance, In March 2021, Cipla Therapeutics, a division of Cipla USA Inc., an affiliate of Cipla Limited, and SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on health security market announced a strategic partnership to deliver sustained innovation and access to novel antibacterial drugs, particularly against bio threats such as tuberculosis and others.
Furthermore, In April 2017, R-Pharm Group, a specialty pharmaceutical company had announced that it entered into a strategic partnership with Mitsui & Co., Ltd., a Japan-based general trading company which acquired around 10% of R-Pharm Group's shares. This partnership would help R-Pharm Group expand its business presence in Japan
Key features of the study:
Detailed Segmentation:Global Antibacterial Drugs Market, by Drug Class:
Global Antibacterial Drugs Market, by Distribution Channel:
Global Antibacterial Drugs Market, By Region
Company Profiles
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Antibacterial Drugs Market- Impact of Coronavirus (COVID-19) Pandemic
5. Global Antibacterial Drugs Market, By Drug Class, 2017 - 2030, (US$ Mn)
6. Global Antibacterial Drugs Market, By Distribution Channel, 2017 - 2030, (US$ Mn)
7. Global Antibacterial Drugs Market, By Region, 2017 - 2030 (US$ Million)
8. Competitive Landscape
9. Section
For more information about this report visit https://www.researchandmarkets.com/r/hqvs2q
View source version on businesswire.com:https://www.businesswire.com/news/home/20220920005801/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/20/2022 07:28 AM/DISC: 09/20/2022 07:28 AM
http://www.businesswire.com/news/home/20220920005801/en